HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successful use of infliximab in macrophage activation syndrome with severe CNS involvement.

AuthorsA Sellmer, B Stausbøl-Grøn, B Krag-Olsen, T Herlin
JournalScandinavian journal of rheumatology (Scand J Rheumatol) Vol. 40 Issue 2 Pg. 156-7 (Mar 2011) ISSN: 1502-7732 [Electronic] England
PMID20868310 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Cytokines
  • Infliximab
Topics
  • Antibodies, Monoclonal (therapeutic use)
  • Antirheumatic Agents (therapeutic use)
  • Brain (pathology)
  • Central Nervous System Diseases (drug therapy, etiology, pathology)
  • Child
  • Cytokines (metabolism)
  • Dose-Response Relationship, Drug
  • Humans
  • Infliximab
  • Macrophage Activation Syndrome (complications, drug therapy, metabolism)
  • Magnetic Resonance Imaging
  • Male
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: